1. Design, synthesis, and bioevaluation of imidazo [1, 2–a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities. (15th December 2022) Authors: Deng, Bulian; Sun, Zhiqiang; Wang, Yuxi; Mai, Ruiyao; Yang, Zichao; Ren, Yichang; Liu, Jin; Huang, Junli; Ma, Zeli; Chen, Ting; Zeng, Canjun; Chen, Jianjun Journal: Bioorganic & medicinal chemistry Issue: Volume 76(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma. (31st December 2023) Authors: Peng, Xiaopeng; Yu, Ziwen; Surineni, Goverdhan; Deng, Bulian; Zhang, Meizhu; Li, Chuan; Sun, Zhiqiang; Pan, Wanyi; Liu, Yao; Liu, Shenglan; Yu, Bin; Chen, Jianjun Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 38:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗